GLATFELTER CORP (GLT)

US3773201062 - Common Stock

1.535  +0.06 (+4.42%)

Fundamental Rating

1

Taking everything into account, GLT scores 1 out of 10 in our fundamental rating. GLT was compared to 9 industry peers in the Paper & Forest Products industry. GLT has a bad profitability rating. Also its financial health evaluation is rather negative. GLT has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

In the past year GLT has reported negative net income.
GLT had a negative operating cash flow in the past year.
In multiple years GLT reported negative net income over the last 5 years.
In multiple years GLT reported negative operating cash flow during the last 5 years.

1.2 Ratios

With a Return On Assets value of -5.06%, GLT is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
GLT has a Return On Equity of -30.78%. This is in the lower half of the industry: GLT underperforms 77.78% of its industry peers.
With a Return On Invested Capital value of 1.23%, GLT perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for GLT is significantly below the industry average of 11.25%.
Industry RankSector Rank
ROA -5.06%
ROE -30.78%
ROIC 1.23%
ROA(3y)-5.49%
ROA(5y)-3.3%
ROE(3y)-30.19%
ROE(5y)-18.15%
ROIC(3y)1.29%
ROIC(5y)2.28%

1.3 Margins

Looking at the Operating Margin, with a value of 1.45%, GLT is in line with its industry, outperforming 44.44% of the companies in the same industry.
GLT's Operating Margin has declined in the last couple of years.
The Gross Margin of GLT (9.36%) is worse than 66.67% of its industry peers.
GLT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.45%
PM (TTM) N/A
GM 9.36%
OM growth 3Y-34.91%
OM growth 5Y-7.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.6%
GM growth 5Y-9.06%

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GLT is destroying value.
The number of shares outstanding for GLT has been increased compared to 1 year ago.
GLT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for GLT is higher compared to a year ago.

2.2 Solvency

GLT has an Altman-Z score of 1.58. This is a bad value and indicates that GLT is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.58, GLT is in line with its industry, outperforming 44.44% of the companies in the same industry.
GLT has a Debt/Equity ratio of 3.35. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 3.35, GLT is doing worse than 88.89% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 3.35
Debt/FCF N/A
Altman-Z 1.58
ROIC/WACC0.2
WACC6.26%

2.3 Liquidity

A Current Ratio of 2.16 indicates that GLT has no problem at all paying its short term obligations.
GLT has a Current ratio of 2.16. This is comparable to the rest of the industry: GLT outperforms 55.56% of its industry peers.
GLT has a Quick Ratio of 1.10. This is a normal value and indicates that GLT is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.10, GLT is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.16
Quick Ratio 1.1

1

3. Growth

3.1 Past

GLT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -93.18%.
GLT shows a decrease in Revenue. In the last year, the revenue decreased by -7.10%.
The Revenue has been growing by 9.85% on average over the past years. This is quite good.
EPS 1Y (TTM)-93.18%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q75%
Revenue 1Y (TTM)-7.1%
Revenue growth 3Y14.77%
Revenue growth 5Y9.85%
Revenue growth Q2Q-14.31%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

GLT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

GLT's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.45

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for GLT!.
Industry RankSector Rank
Dividend Yield N/A

GLATFELTER CORP

NYSE:GLT (4/19/2024, 2:11:21 PM)

1.535

+0.06 (+4.42%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap69.31M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.06%
ROE -30.78%
ROCE
ROIC
ROICexc
ROICexgc
OM 1.45%
PM (TTM) N/A
GM 9.36%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 3.35
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.16
Quick Ratio 1.1
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-93.18%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-7.1%
Revenue growth 3Y14.77%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y